Total Payments
$25,411
2024 Payments
$13,733
Companies
18
Transactions
145
Medicare Patients
2,907
Medicare Billing
$280,280
Payment Breakdown by Category
Consulting$17,905 (70.5%)
Food & Beverage$4,648 (18.3%)
Travel$2,209 (8.7%)
Other$650.00 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,905 | 4 | 70.5% |
| Food and Beverage | $4,648 | 127 | 18.3% |
| Travel and Lodging | $2,209 | 10 | 8.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $650.00 | 2 | 2.6% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$25,411
143 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $11,522 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $9,150 | 22 | $0 (2024) |
| ABBVIE INC. | $2,694 | 50 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $379.37 | 6 | $0 (2024) |
| Celgene Corporation | $333.78 | 35 | $0 (2024) |
| Boston Scientific Corporation | $308.30 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $204.59 | 3 | $0 (2023) |
| Intuitive Surgical, Inc. | $169.59 | 2 | $0 (2021) |
| Allergan Inc. | $124.67 | 1 | $0 (2017) |
| Dova Pharmaceuticals | $122.69 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,733 | 38 | GENZYME CORPORATION ($11,522) |
| 2023 | $957.57 | 20 | ABBVIE INC. ($675.24) |
| 2022 | $1,206 | 51 | ABBVIE INC. ($641.91) |
| 2021 | $966.22 | 8 | AbbVie Inc. ($753.33) |
| 2020 | $158.91 | 2 | CONMED Corporation ($117.76) |
| 2019 | $393.91 | 5 | AbbVie, Inc. ($125.00) |
| 2018 | $7,727 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($7,175) |
| 2017 | $268.82 | 3 | Allergan Inc. ($124.67) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.34 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $89.52 | General |
| Category: Immunology | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $34.57 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: Neuroscience | ||||||
| 08/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.10 | General |
| Category: Neuroscience | ||||||
| 08/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $10,115.00 | General |
| Category: Immunology | ||||||
| 08/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $596.15 | General |
| Category: Immunology | ||||||
| 08/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $333.17 | General |
| Category: Immunology | ||||||
| 08/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $198.41 | General |
| Category: Immunology | ||||||
| 08/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $155.00 | General |
| Category: Immunology | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.03 | General |
| Category: Neuroscience | ||||||
| 06/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.03 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.37 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.39 | General |
| Category: Neuroscience | ||||||
| 06/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Gastroenterology | ||||||
| 05/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.69 | General |
| Category: Neuroscience | ||||||
| 04/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.80 | General |
| Category: Neuroscience | ||||||
| 04/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 665 | 712 | $330,483 | $73,973 |
| 2022 | 11 | 706 | 736 | $327,224 | $75,766 |
| 2021 | 13 | 879 | 933 | $555,617 | $77,878 |
| 2020 | 11 | 657 | 686 | $238,572 | $52,664 |
Total Patients
2,907
Total Services
3,067
Medicare Billing
$280,280
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 138 | 138 | $99,972 | $26,037 | 26.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 89 | 94 | $41,522 | $8,901 | 21.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 111 | 112 | $64,295 | $8,258 | 12.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 137 | 140 | $55,972 | $7,762 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 85 | $17,341 | $6,894 | 39.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 31 | 31 | $13,144 | $5,311 | 40.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 27 | 28 | $14,828 | $3,638 | 24.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $12,395 | $2,691 | 21.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $6,360 | $2,521 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 20 | $2,860 | $1,355 | 47.4% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 14 | 14 | $1,794 | $606.14 | 33.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 154 | 155 | $102,280 | $29,003 | 28.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 85 | 86 | $33,881 | $8,439 | 24.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 161 | 161 | $58,711 | $8,199 | 14.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 128 | 129 | $70,509 | $7,553 | 10.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 38 | 38 | $15,680 | $6,758 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 70 | $12,282 | $5,913 | 48.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $13,316 | $2,941 | 22.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 22 | $10,393 | $2,614 | 25.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $5,864 | $2,479 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,504 | $1,611 | 46.0% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 12 | 12 | $804.00 | $257.04 | 32.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 157 | 160 | $143,993 | $30,559 | 21.2% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 107 | 114 | $123,408 | $10,335 | 8.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 170 | 176 | $102,023 | $7,514 | 7.4% |
About Dr. Eric Eliason, D.O
Dr. Eric Eliason, D.O is a Gastroenterology healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760692602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Eliason, D.O has received a total of $25,411 in payments from pharmaceutical and medical device companies, with $13,733 received in 2024. These payments were reported across 145 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($17,905).
As a Medicare-enrolled provider, Eliason has provided services to 2,907 Medicare beneficiaries, totaling 3,067 services with total Medicare billing of $280,280. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Ogden, UT
- Active Since 05/22/2007
- Last Updated 09/29/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1760692602
Products in Payments
- DUPIXENT (Biological) $11,726
- Entyvio (Biological) $7,251
- EOHILIA (Drug) $1,695
- SKYRIZI (Biological) $1,088
- RINVOQ (Biological) $673.74
- XIFAXAN (Drug) $341.51
- LINZESS (Drug) $336.61
- ZEPOSIA (Drug) $333.78
- ENTYVIO (Biological) $203.50
- CREON (Drug) $170.43
- Da Vinci Surgical System (Device) $169.59
- EXALT Model D (Device) $154.07
- HUMIRA (Biological) $132.34
- Creon (Drug) $125.00
- Doptelet (Drug) $122.69
- CONMED BILIARY (Device) $117.76
- Humira (Biological) $114.26
- ESOPHYX (Device) $95.35
- Smoflipid (Drug) $85.31
- ORISE (Device) $70.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Ogden
Dr. Kyle Eliason, M.d, M.D
Gastroenterology — Payments: $102,451
Gastroenterology $102,451
Chad Gonzales, M.d, M.D
Gastroenterology — Payments: $51,277
Gastroenterology $51,277
Jeffrey Poole, Md, MD
Gastroenterology — Payments: $8,888
Gastroenterology $8,888
Joshua Vandersteen, Do, DO
Gastroenterology — Payments: $7,326
Gastroenterology $7,326
Robert Ziegler, Md, MD
Gastroenterology — Payments: $2,344
Gastroenterology $2,344
John Lowe, Md, MD
Gastroenterology — Payments: $1,952
Gastroenterology $1,952